Cancer News and Research

Latest Cancer News and Research

Study shows increase in IL-6 secretion can reduce Tarceva sensitivity to treat lung tumor cells

One of the most tantalizing developments in anti-cancer therapy over recent years has been the advent of targeted treatments, which have proven highly effective in holding aggressive cancers at bay in certain patients, although typically only for a limited period of time.

18 Aug 2010

Long-term entecavir therapy suppresses HBV DNA, normalizes ALT and improves liver histology

Researchers from this international study found that patients with chronic hepatitis B virus (HBV) infection who received at least 3 years of cumulative entecavir (antiviral) therapy achieved substantial histologic improvement and regression of fibrosis or cirrhosis. Full details of the study appear in the September issue of Hepatology, a journal published by Wiley-Blackwell on behalf of the American Association for the Study of Liver Diseases (AASLD).

18 Aug 2010

Iyengar yoga program improves quality of life for breast cancer patients

University of Alberta research fellow Amy Speed-Andrews has examined how a specialized Iyengar yoga program for women currently in treatment for breast cancer, and who have completed treatment, makes a difference in their recovery.

18 Aug 2010

Virginia creates health law panel, groups prepare for overhaul changes

Virginia has created a task force to slow health costs and implement health care reform even as the state is suing to stop a key mandate in the law, The Washington Post reports. Gov. Bob McDonnell "introduced the 24-member panel, comprised of legislators, health professionals, doctors and insurers, at a news conference Monday afternoon at the Capitol.

18 Aug 2010

Emerson Ecologics announces exclusive distribution of EcoNugenics' ProstaCaid supplement

Emerson Ecologics, LLC, the leading provider of professional-grade nutritional supplements to the healthcare practitioner market, announces the exclusive distribution of EcoNugenics' newest product ProstaCaid™ to healthcare practitioners. A professional dietary supplement based on the latest in prostate research, ProstaCaid is specifically formulated to promote and maintain prostate health.

18 Aug 2010

Researcher identifies immune system's ability to protect body against lung cancer

A Michigan State University researcher is analyzing the immune system's own ability to protect the body against lung cancer.The results of the work by Alison Bauer, an assistant professor of pathobiology and diagnostic investigation in the College of Veterinary Medicine, are expected to provide new approaches to prevent, identify and treat lung cancer.

18 Aug 2010

Breast cancer accomplice discovered

Scientists have discovered an accomplice in breast cancer - a master control switch with the power to set off a cascade of reactions orchestrated by a cancer-causing gene (or oncogene) named Wnt1. This executive molecule and its modus operandi are reported in back-to-back papers featured on the cover of the August 15 issue of Cancer Research.

18 Aug 2010

Adult stem cells associated with poor prognosis of cancer: Research

Adult stem cells that are vital for airway repair in the lung but that persist in areas where pre-cancerous lesions are found are associated with a poor prognosis in patients who develop cancer, even those with early stage disease, researchers at UCLA's Jonsson Comprehensive Cancer Center have found.These adult stem cells are found in repairing areas after injury and also are found in pre-cancerous areas, suggesting that these cells may mutate and become cancer causing stem cells, making them a potential cell-of-origin for lung cancer and a possible target for prevention strategies and new targeted therapies.

18 Aug 2010

Cryo-Cell International collaborates with MNSH to identify potential therapy for autoimmune diseases

Cryo-Cell International, Inc., one of the largest and most established leaders in stem cell innovation, today announced a research and development collaboration agreement with Monash University in Australia. The partnership will allow scientists from the University's Centre of Inflammatory Diseases to conduct pre-clinical studies using Cryo-Cell's proprietary C'elle menstrual stem cell technology (MenScs) to identify potential future therapies to treat autoimmune diseases such as multiple sclerosis.

18 Aug 2010

NCI grants SBIR award to MabVax Therapeutics

MabVax Therapeutics, Inc., a privately held clinical stage biotechnology company focused on the development of vaccine and antibody based therapies to address the unmet medical need of preventing recurrent cancer, announces that it has received a Small Business Innovation Research Grant (SBIR) from the National Cancer Institute (NCI) under the agency's Streamlined Non-competing Award Procedures (SNAP).

18 Aug 2010

ImmunoCellular Therapeutics raises $6.5 million in second quarter 2010

ImmunoCellular Therapeutics today announced second quarter results for the period ended June 30, 2010. The Company utilized $1.13 million of cash in its operations during the quarter. The increase in net burn is reflective of increased personnel costs as well as increase in Research and Development costs associated with the planned phase II clinical trial for ICT-107.

18 Aug 2010

Cancer is the world's top 'economic killer,' report finds

The Associated Press: "Cancer is the world's top 'economic killer' as well as its likely leading cause of death, the American Cancer Society contends in a new report it will present at a global cancer conference in China this week. Cancer costs more in productivity and lost life than AIDS, malaria, the flu and other diseases that spread person-to-person, the report concludes.

18 Aug 2010

Acupuncture not superior to sham acupuncture in knee osteoarthritis

17 Aug 2010

Long-term Entecavir therapy reverses fibrosis and cirrhosis in chronic hepatitis B patients

17 Aug 2010

Chronix Biomedical expands biomarker development capabilities with installation of DNA mass sequencer

Chronix Biomedical today reported that it has significantly expanded and accelerated its biomarker development capabilities with the installation of Germany's first state-of-the-art high-throughput DNA mass sequencer at the University of Göttingen, Chronix's long-time collaborator. Chronix is developing disease-specific biomarkers based on DNA fragments that are released into the bloodstream by damaged and dying (apoptotic) cells.

17 Aug 2010

Study finds sham acupuncture superior to traditional Chinese acupuncture in osteoarthritis treatment

Researchers from MD Anderson Cancer Center determined patients with osteoarthritis (OA) of the knee who are treated with traditional Chinese acupuncture (TCA) do not experience any more benefit than those receiving sham acupuncture (placebo). The team did find that the communication style of the acupuncturist could have a significant effect on pain reduction and satisfaction in patients. Full findings are now online and will publish in the September print issue of Arthritis Care & Research, a journal of the American College of Rheumatology.

17 Aug 2010

Pisgah Labs receives Notice of Allowance for new patent relating to thyroid hormone drugs

Today, Pisgah Labs, Inc. received a Notice of Allowance from the United States Patent and Trademark office for an important new technology patent addressing global stability problems of thyroid hormone drugs.

17 Aug 2010

First Edition: August 17, 2010

Today's headlines include news about new federal funding to help states regulate rising health insurance premiums and more information about the costs of cancer.

17 Aug 2010

Cancer Institute of New Jersey expands 'Quality and Outcomes in Cancer Care Research Program'

Looking to gain further understanding about the impact of cancer on patients and families, The Cancer Institute of New Jersey (CINJ) is expanding its Quality and Outcomes in Cancer Care (QOCC) Research Program by welcoming nationally-recognized population science researcher Sharon Manne, PhD. Dr. Manne, who is the recipient of major grant awards from the National Institutes of Health (NIH) for her work in behavioral science, was most recently at the Fox Chase Cancer Center in Philadelphia. CINJ is a Center of Excellence of UMDNJ-Robert Wood Johnson Medical School.

17 Aug 2010

European Cancer Cluster Meeting 2010 to be held September 15-17 in Oslo, Norway

Europe's most promising oncology biotechs and other key stakeholders will gather in Oslo, Norway, September 15-17 for the 2nd European Cancer Cluster Meeting (ECCP 2010). Co-hosted by the Oslo Cancer Cluster and the Cancer-Bio-Santé Cluster from Toulouse, the two-day meeting is a unique partnering opportunity for oncology biotech companies, business development and licensing executives from the pharmaceutical industry and investors, as well as innovative researchers and clinicians.

17 Aug 2010

Cancer News and Research

Latest Cancer News and Research

Study shows increase in IL-6 secretion can reduce Tarceva sensitivity to treat lung tumor cells

Long-term entecavir therapy suppresses HBV DNA, normalizes ALT and improves liver histology

Iyengar yoga program improves quality of life for breast cancer patients

Virginia creates health law panel, groups prepare for overhaul changes

Emerson Ecologics announces exclusive distribution of EcoNugenics' ProstaCaid supplement

Researcher identifies immune system's ability to protect body against lung cancer

Breast cancer accomplice discovered

Adult stem cells associated with poor prognosis of cancer: Research

Cryo-Cell International collaborates with MNSH to identify potential therapy for autoimmune diseases

NCI grants SBIR award to MabVax Therapeutics

ImmunoCellular Therapeutics raises $6.5 million in second quarter 2010

Cancer is the world's top 'economic killer,' report finds

Acupuncture not superior to sham acupuncture in knee osteoarthritis

Long-term Entecavir therapy reverses fibrosis and cirrhosis in chronic hepatitis B patients

Chronix Biomedical expands biomarker development capabilities with installation of DNA mass sequencer

Study finds sham acupuncture superior to traditional Chinese acupuncture in osteoarthritis treatment

Pisgah Labs receives Notice of Allowance for new patent relating to thyroid hormone drugs

First Edition: August 17, 2010

Cancer Institute of New Jersey expands 'Quality and Outcomes in Cancer Care Research Program'

European Cancer Cluster Meeting 2010 to be held September 15-17 in Oslo, Norway

Industry Focus eBook: Oncology eBook

How the Vutara VXL simplifies single-molecule imaging

How cohesin mechanics and nanotracker tech are redefining DNA research

Todd Bauman and Chris Povich

Cancer News and Research

Latest Cancer News and Research

Industry Focus eBook: Oncology eBook

How the Vutara VXL simplifies single-molecule imaging

How cohesin mechanics and nanotracker tech are redefining DNA research

Todd Bauman and Chris Povich

Newsletters you may be interested in